Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

NXP Semiconductors (NXPI) Margin Decline Challenges Bullish Earnings Growth Narratives

NXP Semiconductors (NXPI) just wrapped up FY 2025 with Q4 revenue of US$3.3b and basic EPS of US$1.80, anchored by net income of US$455m, setting the stage for how investors read the year as a whole. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.3b in Q4 2025, alongside quarterly EPS shifting from US$1.95 to US$1.80, which feeds into trailing twelve month EPS of US$8.00 on revenue of US$12.3b. With trailing net income of US$2.0b and a reported net margin that has...
OM:VITR
OM:VITRBiotechs

Vitrolife (OM:VITR) Is Down 24.1% After Impairment-Driven Loss And Maintained Dividend Proposal Has The Bull Case Changed?

Vitrolife AB reported fourth-quarter 2025 sales of SEK 891 million and a full-year net loss of SEK 5,012 million, while its Board proposed an unchanged dividend of SEK 1.10 per share for approval at the upcoming Annual General Meeting. The sharp swing from prior-year profit to a very large loss, driven by impairment and restructuring costs, contrasts with continued organic sales growth and a maintained dividend proposal. We’ll now examine how the large impairment-driven loss, alongside...
SEHK:1672
SEHK:1672Biotechs

Ascletis Pharma (SEHK:1672) Is Up 5.4% After HK$844m Follow-On Offering And Positive Phase III Acne Data - Has The Bull Case Changed?

Ascletis Pharma recently filed a follow-on equity offering of HK$843.54 million via a subsequent direct listing, issuing 69,256,000 ordinary shares at HK$12.18 each. The fundraising follows positive Phase III data for denifanstat in moderate-to-severe acne and progress with ASC30 in metabolic disease, underscoring Ascletis’s late-stage pipeline momentum. We’ll now explore how this combination of positive Phase III acne data and a sizable equity raise shapes Ascletis Pharma’s investment...
TSE:3116
TSE:3116Auto Components

Toyota Boshoku (TSE:3116) Valuation Check After Strong Profit Recovery And Steady Dividend

Toyota Boshoku (TSE:3116) has drawn attention after reporting higher nine-month profits. The company reaffirmed expectations for a strong full-year recovery, kept its dividend unchanged, and pointed to improved asset and equity ratios. See our latest analysis for Toyota Boshoku. The latest earnings update appears to have supported stronger momentum, with a 1-day share price return of 4.53% and a 90-day share price return of 21.82%. The 1-year total shareholder return of 48.59% points to gains...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Resets Portfolio With Janus Living Spin Off And Tech Push

Healthpeak Properties (NYSE:DOC) is planning an IPO of Janus Living to spin off its senior housing assets. The company has announced a $1b capital recycling program to reshape its real estate portfolio. Healthpeak also hired a former Palantir executive as Head of Enterprise Innovation to focus on technology and data driven operations. Healthpeak Properties, trading at $16.45, is reshaping its portfolio around core healthcare real estate while separating senior housing into the new Janus...
NYSE:CLF
NYSE:CLFMetals and Mining

Rising Earnings Optimism Might Change The Case For Investing In Cleveland-Cliffs (CLF)

Cleveland-Cliffs, expected as of early February to report higher year-over-year earnings and revenue for the quarter ended December 2025, was viewed by analysts as a candidate to outperform earnings forecasts, ahead of its scheduled February 9 release. This growing analyst optimism around Cleveland-Cliffs’ earnings prospects has become a key driver of investor attention, potentially reshaping how the company’s near-term fundamentals are perceived. Next, we’ll explore how this rising...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Did Vericel's (VCEL) GARP Label and Debt-Free Balance Sheet Reframe Its Growth Narrative?

Analysts recently highlighted Vericel as a Growth at a Reasonable Price candidate, citing strong momentum in its earnings and revenue forecasts alongside a debt-free balance sheet and solid profitability metrics. This combination of projected earnings expansion, revenue growth and financial strength positions Vericel as a case study in how growth-focused investors may view profitable, balance-sheet-light businesses. With robust earnings growth projections at the center of the story, we’ll...
NYSE:BOOT
NYSE:BOOTSpecialty Retail

A Look At Boot Barn (BOOT) Valuation As Q3 Earnings Approach And Expansion Plans Stay On Track

Why Boot Barn’s upcoming earnings matter now Boot Barn Holdings (BOOT) heads into its Q3 2026 earnings release and call this afternoon, with investors watching whether prior quarters’ better than expected results and ongoing store expansion plans align with signs of moderating consumer demand. See our latest analysis for Boot Barn Holdings. At a share price of $181.82, Boot Barn’s 7 day share price return of 1.75% contrasts with a modest 30 day share price decline of 2.58%, while its 5 year...
NYSE:UPS
NYSE:UPSLogistics

UPS Overhaul Weighs RFID Automation Against Amazon Pullback And Margins

United Parcel Service (NYSE:UPS) is rolling out RFID package tracking across all UPS Store locations as part of a wider technology refresh. The company is investing in higher automation in its network, targeting more efficient sorting and handling of parcels. UPS is intentionally reducing Amazon related volumes while focusing on healthcare and small and medium sized business customers. The overhaul includes facility closures and cost saving measures that collectively reshape how UPS runs its...
NasdaqGS:COLM
NasdaqGS:COLMLuxury

Columbia Sportswear (COLM) Is Up 6.0% After Beating Guidance And Issuing Cautious 2026 Outlook – Has The Bull Case Changed?

Columbia Sportswear recently reported fourth-quarter and full-year 2025 results that exceeded its own guidance, issued 2026 earnings and sales forecasts calling for modest growth, and affirmed a regular quarterly dividend of US$0.30 per share payable on March 20, 2026. The company highlighted that stronger-than-expected U.S. demand, broad-based international growth, and its ACCELERATE Growth initiatives helped offset weather and tariff pressures while supporting a cautiously constructive...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Why Doximity (DOCS) Is Down 10.5% After AI Disruption Fears Hit Tech-Health Software Stocks

Doximity recently came under pressure as part of a broader sell-off in technology and healthcare software stocks, driven by investor worries about potential disruption from artificial intelligence. Despite this pressure, analyst expectations still point to higher quarterly revenue and growth in larger customers, even as projected earnings per share soften slightly compared to a year earlier. Given the recent 10.5% seven-day share price decline, we'll examine how AI-disruption concerns shape...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Is Moderna (MRNA) Pricing Reflect Long Term Potential After Recent 36.7% Surge?

If you are wondering whether Moderna's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are saying about value. Moderna's stock recently closed at US$42.20, with a 30 day return of 36.7%, a 7 day return reflecting a 7.2% decline, and a 3 year return showing a 75.3% decline. This contrasts with a 23.5% gain over the last year and a 36.7% return year to date. Recent coverage has focused on how investors are reassessing vaccine...
SGX:9CI
SGX:9CIReal Estate

Does CapitaLand Investment’s Higher S$0.039 Payout Reveal Its Capital Priorities for SGX:9CI Investors?

CapitaLand Investment Limited has announced a distribution of S$0.039 per unit for the period from 1 July 2025 to 31 December 2025, with the ex-distribution date on 12 February 2026, record date on 13 February 2026, and payment scheduled for 19 March 2026. This latest distribution decision highlights CapitaLand Investment’s continued emphasis on cash returns to unitholders, with clear timelines that may help income-focused investors plan their portfolios. Next, we’ll explore how this higher...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Is Cooper’s Debt Extension And Fresh Institutional Interest Reframing The Investment Case For COO?

In the past few days, The Cooper Companies amended its 2021 term loan agreement, extending US$950 million of term loans to February 3, 2031, while lifting the cap on incremental borrowing and adding optional rating-based pricing. At the same time, Diamond Hill Capital’s Large Cap Fund disclosed a new position in the company, underscoring institutional interest in its contact lens and women’s health and fertility businesses despite current headwinds. Next, we’ll examine how the extended debt...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

Assessing AXT (AXTI) Valuation As AI Optics Demand Lifts Investor Interest

AXT (AXTI) is back on many watchlists after investor interest climbed alongside AI driven bandwidth demand, as the company’s Indium Phosphide substrate wafers sit at the heart of data center and optical communications build outs. See our latest analysis for AXT. AXT’s share price has been highly volatile, with a 14.8% 7 day share price return and a 116.9% 90 day share price return. The 1 year total shareholder return is extremely large, pointing to strong momentum despite the recent 5.7% 1...
NYSE:ATO
NYSE:ATOGas Utilities

Atmos Energy (ATO) Valuation Check After Earnings Beat Guidance Confirmation And Ongoing Dividend

Why Atmos Energy (ATO) is on investors’ radar after its latest results Atmos Energy (ATO) recently reported first quarter earnings, with sales and net income figures above the prior year period. The company also affirmed full year earnings guidance and continued its long running quarterly dividend. See our latest analysis for Atmos Energy. Despite a relatively muted 90 day share price return of a 2.19% decline to US$168.81, Atmos Energy’s 1 year and 5 year total shareholder returns of 21.22%...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Is Kyivstar Group (KYIV) Pricing In Ukraine Conflict Risks Or Market Opportunity?

If you are wondering whether Kyivstar Group's current share price reflects its true worth, you are not alone. This article focuses squarely on that question. The stock recently closed at US$11.83, with a 7 day return of 6.0% decline, a 30 day return of 10.9% decline, and a 1 year return of 14.4%, which points to shifting expectations and risk perceptions over different time frames. Recent news coverage around Kyivstar Group has focused on its position as a US listed telecom player with...
ASX:GMD
ASX:GMDMetals and Mining

Assessing Genesis Minerals (ASX:GMD) Valuation After Leadership Restructure And Evolving Growth Focus

Genesis Minerals (ASX:GMD) has shaken up its leadership, shifting Raleigh Finlayson to Executive Chair and promoting Matthew Nixon to CEO, as the miner aims to align governance, growth plans and day-to-day operations. See our latest analysis for Genesis Minerals. The leadership reshuffle comes after a mixed short term run, with a 2.96% 1 day share price return and a 10.09% 7 day share price decline. This is set against a 24.32% 90 day share price return and a very large 5 year total...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD’s AI Momentum Meets Valuation Appeal And New On Device Partnerships

Advanced Micro Devices (NasdaqGS:AMD) reported Q4 2025 results that exceeded prior expectations, driven by AI focused data center products. The company issued cautious Q1 2026 guidance, raising questions about how quickly AI related demand will translate into near term growth. AMD expanded its partnership with GIGABYTE to bring its AI technology more deeply into consumer and creator devices, extending beyond data centers. With a current share price of $242.11, Advanced Micro Devices has...
NYSE:IOT
NYSE:IOTSoftware

Samsara Canada Push Highlights Localized Growth Potential And Valuation Gap

Samsara (NYSE:IOT) is expanding its Canadian footprint with local data hosting, domestic logistics partnerships, and new AI safety features. The rollout focuses on data residency, regional hardware fulfillment, and support for customers operating in remote parts of Canada. The company is tailoring its connected operations platform to Canadian fleets and industrial operators that face strict compliance and connectivity requirements. Samsara runs a connected operations platform that links...
ASX:OCL
ASX:OCLSoftware

Objective (ASX:OCL) Valuation Check After 10% Share Buyback Approval

Objective (ASX:OCL) has drawn fresh attention after its board approved an on market buyback of up to 9,590,176 shares, or 10% of issued capital, running through to February 5, 2027. See our latest analysis for Objective. That buyback decision comes after a stretch of weaker momentum, with the share price at A$14.63 and a 90 day share price return showing a decline of 21.05%, while the 5 year total shareholder return of 13.72% remains in positive territory. If this kind of capital management...
NYSE:TT
NYSE:TTBuilding

Is Trane Technologies (TT) Still Reasonably Priced After Strong Multi Year Share Price Gains

If you are wondering whether Trane Technologies at around US$435 a share still offers reasonable value, you are not alone. This article is aimed at helping you frame that question clearly. The stock has posted returns of 11.0% over the last 7 days, 9.4% over the past month and year to date, and 23.6% over the past year, with a very large 3 year gain and a 219.1% return over 5 years that may be influencing how the market is thinking about future expectations and risk. Recent coverage has...
ENXTAM:HAL
ENXTAM:HALDiversified Financial

How HAL Trust’s €3.50 Dividend Decision Will Impact HAL Trust (ENXTAM:HAL) Investors

HAL Trust has announced an annual dividend of €3.50 per share, with an ex-dividend date of 14 May 2026, a record date of 15 May 2026, and payment scheduled for 21 May 2026. This dividend decision highlights how the trust is choosing to return capital to investors, which can influence perceptions of income stability and capital allocation. We will now explore how HAL Trust’s €3.50 per share annual dividend shapes its investment narrative, particularly for income-focused investors. We've found...
NYSE:SNOW
NYSE:SNOWIT

Snowflake OpenAI Deal Puts AI Agents At Center Of Growth Debate

Snowflake (NYSE:SNOW) has entered a multi year, $200 million partnership with OpenAI to embed advanced AI models directly into its data platform. The company is launching Cortex Code, an AI coding agent built around customer data, alongside new tools aimed at enterprise AI development and governance. These updates are designed to let enterprises build custom AI agents on their own data while keeping control, security and compliance within Snowflake’s environment. Snowflake is pushing deeper...